Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$782K Sell
6,500
-120,000
-95% -$13.9M ﹤0.01% 1091
2025
Q4
$13.3M Buy
126,500
+121,899
+2,649% +$11.4M 0.09% 255
2025
Q3
$386K Sell
4,601
-2,299
-33% -$189K ﹤0.01% 1360
2025
Q2
$546K Buy
+6,900
New +$548K 0.01% 1090
2024
Q1
Sell
-12,600
Closed -$1.55M 1515
2023
Q4
$1.37M Buy
+12,600
New +$1.31M 0.02% 731
2022
Q2
Sell
-18,000
Closed -$1.6M 1692
2022
Q1
$1.48M Sell
18,000
-71,000
-80% -$5.6M 0.02% 847
2021
Q4
$6.82M Sell
89,000
-151,000
-63% -$12M 0.08% 358
2021
Q3
$18M Buy
240,000
+228,800
+2,043% +$17.4M 0.21% 113
2021
Q2
$871K Buy
+11,200
New +$833K 0.01% 932

Other funds holding MRK

Caption Management's MRK Position: Q1 2026 in Review

Caption Management reduced its Merck (MRK) stake by 95% in Q1 2026, selling an estimated $13.9M and leaving 6,500 shares worth $782K. The position accounts for ﹤0.01% of the portfolio, ranked #1091.

Caption Management first reported a position in MRK in Q2 2021 and has held it in 9 quarters since. The position peaked at $18M in Q3 2021. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Caption Management held 6,500 shares of Merck worth $782K as of Q1 2026.
  • Caption Management sold 120,000 Merck shares in Q1 2026, an estimated $13.9M.
  • Merck made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1091 holding.
  • Caption Management first reported a position in Merck in Q2 2021 and has held it in 9 quarters since.
  • Caption Management's Merck position peaked at $18M in Q3 2021.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.